Monday, August 19, 2019
Connectivity to Roche analyzers
Astraia is very glad to announce working with Roche Russia, we have finished development and released an interface between our system astraia – database for women’s health and the Roche analyzers Cobas e411 and 6000.
Via this interface concentrations of the pregnancy hormones free ß-HCG, PAPP-A, PlGF and sFlt-1 can be transferred from the analyzer to the respective fields in the latest Risk Module from the Fetal Medicine Foundation, integrated in astraia.
In addition, in 2nd and 3rd Trimesters, by transferring concentrations of sFlt-1 and PlGF the ratio sFlt-1/PlGF will be calculated in astraia.
The assessment of risks for Trisomies (in 1st Trimester) and Pre-Eclampsia (in up to four sessions from 1st Trimester till shortly before delivery) gains by use of those biochemical markers significant improvement in detection rate.
This interface is available in Russia only. We are exploring options to make it available to other countries.
We thank the team of Roche Russia for the good co-operation.